Jc. Corton et al., IDENTIFICATION OF A CELL-SPECIFIC TRANSCRIPTION ACTIVATION DOMAIN WITHIN THE HUMAN AH RECEPTOR NUCLEAR TRANSLOCATOR, Toxicology and applied pharmacology, 139(2), 1996, pp. 272-280
In the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and rela
ted chemicals, the Ah receptor nuclear translocator (Arnt) forms a het
erodimeric complex with the ligand-bound Ah receptor, leading to recog
nition of dioxin-responsive elements within the enhancer of the CYP1A1
gene and transcription activation by an unknown mechanism. To underst
and the role of Arnt in transcription activation by the Ah receptor-Ar
nt heterodimer, we performed a deletion analysis of Arnt to locate dom
ains that are directly involved in transcription activation. We showed
that the C-terminal 34 amino acids of Arnt encode a transcription act
ivation domain (TAD) that functions independently of other sequences i
n the Ah receptor complex when attached to the heterologous Gal4 DNA b
inding domain. Deletion of the C-terminal acidic-rich 14 amino acids c
ompletely abolishes activity. Sequences important in Arnt TAD function
were independent of the glutamine-rich region which is an important s
tructural feature in the TAD of other transcription factors. The stren
gth of the Arnt TAD when compared with the strong TAD from the herpes
simplex virus VP16 protein was cell-type specific. Both the Arnt and V
P16 TAD were equally strong in COS-1 cells, but the Arnt TAD had weak
activity in an Arnt-deficient mouse hepatoma cell line and was not nee
ded for restoration of CYP1A1 activation. These results imply that for
CYP1A1 activation the Ah receptor provides the dominant activation fu
nction for the heterodimer in hepatoma cells. The potential of the Arn
t TAD to contribute to activation by the Ah receptor complex is likely
determined by availability or activity of cell-specific factors with
which the TAD interacts. (C) 1996 Academic Press, Inc.